Pharmacokinetic/Pharmacodynamic Modeling of Luteinizing Hormone (LH) Suppression and LH Surge Delay by Cetrorelix after Single and Multiple Doses in Healthy Premenopausal Women-Reference-Cited by-同舟云学术

Pharmacokinetic/Pharmacodynamic Modeling of Luteinizing Hormone (LH) Suppression and LH Surge Delay by Cetrorelix after Single and Multiple Doses in Healthy Premenopausal Women

Published:2003-03 Issue:3 Volume:43 Page:243-251
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Nagaraja Nelamangala V.,Pechstein Birgit,Erb Katharina,Klipping Christine,Hermann Robert,Locher Mathias,Derendorf Hartmut

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference22 articles.

1. Cetrorelix;Reissman;Drugs of the Future,1994

2. Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist cetrorelix in healthy female volunteers;Duijkers;Hum Reprod,1998

3. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist cetrorelix during ovarian stimulation;Diedrich;Hum Reprod,1994

4. A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge;Leroy;Fertil Steril,1994

5. Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist cetrorelix at different dosages;Felberbaum;J Assist Reprod Genet,1996

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early erythroferrone levels can predict the long‐term haemoglobin responses to erythropoiesis‐stimulating agents;British Journal of Pharmacology;2024-04-23

2. Pivotal Considerations for Optimal Deployment of Healthy Volunteers in Oncology Drug Development;Clinical and Translational Science;2019-10-31

3. Pharmacokinetics and Pharmacodynamics of Therapeutic Peptides and Proteins;Pharmaceutical Biotechnology;2019

4. The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling;British Journal of Clinical Pharmacology;2018-01-18

5. Exploring inductive linearization for pharmacokinetic–pharmacodynamic systems of nonlinear ordinary differential equations;Journal of Pharmacokinetics and Pharmacodynamics;2017-05-26